Reliq Health Technologies Stock Price To Sales
| RQHTF Stock | USD 0 0.0001 10.00% |
Reliq Health Technologies fundamentals help investors to digest information that contributes to Reliq Health's financial success or failures. It also enables traders to predict the movement of Reliq Pink Sheet. The fundamental analysis module provides a way to measure Reliq Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Reliq Health pink sheet.
Reliq |
Reliq Health Technologies Company Price To Sales Analysis
Reliq Health's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Reliq Health Price To Sales | 6.99 X |
Most of Reliq Health's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Reliq Health Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Reliq Health Technologies has a Price To Sales of 6.9894 times. This is 67.34% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The price to sales for all United States stocks is 38.8% higher than that of the company.
Reliq Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Reliq Health's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Reliq Health could also be used in its relative valuation, which is a method of valuing Reliq Health by comparing valuation metrics of similar companies.Reliq Health is currently under evaluation in price to sales category among its peers.
Reliq Fundamentals
| Return On Equity | -0.65 | |||
| Return On Asset | -0.29 | |||
| Profit Margin | (0.39) % | |||
| Operating Margin | (0.45) % | |||
| Current Valuation | 78.18 M | |||
| Shares Outstanding | 196.76 M | |||
| Shares Owned By Insiders | 1.76 % | |||
| Shares Owned By Institutions | 0.01 % | |||
| Price To Earning | (7.07) X | |||
| Price To Book | 16.65 X | |||
| Price To Sales | 6.99 X | |||
| Revenue | 8.55 M | |||
| Gross Profit | 5.3 M | |||
| EBITDA | (8.02 M) | |||
| Net Income | (8.17 M) | |||
| Cash And Equivalents | 890.15 K | |||
| Total Debt | 40 K | |||
| Debt To Equity | 0.05 % | |||
| Current Ratio | 4.61 X | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (8.03 M) | |||
| Earnings Per Share | (0.04) X | |||
| Number Of Employees | 13 | |||
| Beta | 1.52 | |||
| Market Capitalization | 73.78 M | |||
| Total Asset | 10.27 M | |||
| Net Asset | 10.27 M |
About Reliq Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Reliq Health Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Reliq Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Reliq Health Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Reliq Pink Sheet
Reliq Health financial ratios help investors to determine whether Reliq Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Reliq with respect to the benefits of owning Reliq Health security.